Illustrative image – not actual.
MedGenome, a genomics-based diagnostics and research company, has decided to use the Rs. 130 crore ($20 million) funding which it had received from Sequoia Capital to increase capacity at its research lab in Bengaluru.
MedGenome also plans to set up a research lab in the US since transporting samples to India is difficult.
According to the company pharma companies either approach MedGenome with specific problems or the company approaches pharma players that might be interested in funding research that may benefit them.
